Notes from the Field: Characteristics of E-cigarette, or Vaping, Products Confiscated in Public High Schools in California and North Carolina — March and May 2019

An article was released yesterday by CDC's Office on Smoking and Health is releasing the following tobacco-related article in the CDC journal, Morbidity and Mortality Weekly Report (MMWR):

Notes from the Field: Characteristics of E-cigarette, or Vaping, Products Confiscated in Public High Schools in California and North Carolina—March and May 2019

Key findings include:

  • Pod-mods, a type of e-cigarette with prefilled or refillable pod cartridges, were the most commonly confiscated devices from high school youth in California (64%) and North Carolina (74%).
  • More than 1,000 e-cigarette products were confiscated at 25 public high schools in California and North Carolina during the 2018–2019 academic year.
  • E-cigarette, or vaping, products typically contain nicotine, which is highly addictive, can harm adolescent brain development, and prime the brain for addiction.
  • School-level efforts to prevent and reduce e-cigarette use among youth could include adopting and enforcing tobacco-free policies; measures that provide access to resources and treatment for students rather than punishment; implementing evidence-based curricula not sponsored by tobacco companies; and educating school staff and parents about the changing product marketplace and health risks of youth e-cigarette use.

MPI in Missouri - Partners in Prevention webinar series

The MPI recently recorded a webinar with the Partners in Prevention, Missouri's higher education substance misuse coalition. The webinar is part of a recently developed training series in partnership with the PTTC. Our presentation discusses data from the most recent MPI Impact Report, COVID-19 impacts, and future prevention recommendations.

 There are five webinars on a variety of topics related to substance use prevention and they are all free, you just need to register to access the series.  Registration information can be accessed here:



American Society of Addiction Medicine Public Policy Statement on Marijuana

Cannabis is a plant that has been used for its intoxicating effects for at least a century in the United States and for longer in other cultures. It also has a long history of use around the world for purported medical benefits. More than 100 different cannabinoids have been identified in cannabis. The primary intoxicating cannabinoid in cannabis is delta-9-tetrahydrocannabinol (THC). The cannabinoid cannabidiol (CBD) has received increasing public attention in recent years; preliminary findings suggest that CBD may be a useful treatment for several medical conditions and it is not reported to be associated with intoxication or addiction, unlike THC. 1 In this document, the term “cannabis” is used to describe the plant-based products. When the document refers specifically to individual cannabinoids, they are identified as such.

To view complete statement click here.

Diagnosis of EVALI in the COVID-19 era

As of Feb 18, 2020, a total of 2807 cases of e-cigarette, or vaping, product use-associated lung injury (EVALI) and 68 attributed deaths have been reported to the US Centers for Disease Control and Prevention.

Diagnostic criteria for EVALI consists of a mixture of non-specific systemic symptoms (eg, fever, chills, and vomiting) and respiratory symptoms (eg, shortness of breath, cough, chest pain, pnoea, and hypoxia), along with detection of lung opacities on imaging. Diagnosis also depends on identifying a history of vaping and careful exclusion of alternative conditions.
A urine drug screen positive for tetrahydrocannabinol, although non-specific for the disease, might be helpful in this aspect by identifying marijuana-containing electronic cigarettes and vape use.





Associations Between Prenatal Cannabis Exposure and Childhood Outcomes Results From the ABCD Study

Question  Is prenatal exposure to cannabis associated with child outcomes?

Findings  This cross-sectional analysis of 11 489 children (655 exposed to cannabis prenatally) found that prenatal cannabis exposure after maternal knowledge of pregnancy was associated with greater psychopathology during middle childhood, even after accounting for potentially confounding variables.

Meaning  Prenatal cannabis exposure may increase risk for psychopathology; consistent with recent recommendations by the Surgeon General of the United States, these data suggest that cannabis use during pregnancy should be discouraged by clinicians and dispensaries.

To view study click here.